PGRMC1 and endometrial cancer: The actions of PGRMC2 are consistent with prior studies in which PGRMC1 knockdown in endometrial cancer cells dramatically reduced xenograft tumor growth in immunocompromised mice while also elevating chemosensitivity [31].